The first mpox vaccine for children has been approved by The World Health Organization.
The vaccine is approved for children over the age of one.
This comes as Congo and other parts of Africa are being hit the hardest with outbreaks. So far, nearly 50,000 people in Congo have received the vaccine.
The George Washington University has experts available who can offer insight and analysis. If you would like to schedule an interview, please contact Katelyn Deckelbaum, [email protected].
David Diemert is the clinical director of the GW vaccine research unit and professor of medicine at the GW School of Medicine and Health Sciences. He can talk about the risk of mpox spreading in the United States.
Christopher Mores is a professor in the department of global health in the GW School of Medicine and Health Sciences. His research focuses on the role of viral characteristics in determining transmission potential.
Marc Siegel, is an associate professor of medicine at the GW School of Medicine and Health Sciences, and is an infectious disease expert.
RSS